Gene · 773
Papers4,421
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 4,421
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Use of AD Informer Set compounds to explore validity of novel targets in Alzheimer's disease pathology. | Alzheimers Dement (N Y) | 2022 | 35434254 | PubTator, text mining | PubMed |
| Disorders of Sex Development in a Large Ukrainian Cohort: Clinical Diversity and Genetic Findings. | Front Endocrinol (Lausanne) | 2022 | 35432193 | PubTator, text mining | PubMed |
| Expanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population study. | Acta Neuropathol Commun | 2022 | 35428369 | PubTator, text mining | PubMed |
| 'Channeling' therapeutic discovery for epileptic encephalopathy through iPSC technologies. | Trends Pharmacol Sci | 2022 | 35427475 | PubTator, text mining | PubMed |
| Diagnostic efficacy of the magnetic resonance T1w/T2w ratio for the middle cerebellar peduncle in multiple system atrophy and spinocerebellar ataxia: A preliminary study. | PLoS One | 2022 | 35427382 | PubTator, text mining | PubMed |
| Identification of Ion Channel-Related Genes and miRNA-mRNA Networks in Mesial Temporal Lobe Epilepsy. | Front Genet | 2022 | 35422840 | PubTator, text mining | PubMed |
| Bridging Personal and Population in Excitability Diseases: Will Studies of Rare Diseases Bring Generalizable Mechanisms From Monogenic Channelopathies? | Function (Oxf) | 2022 | 35402918 | PubTator, text mining | PubMed |
| Feasibility of Follow-Up Studies and Reclassification in Spinocerebellar Ataxia Gene Variants of Unknown Significance. | Front Genet | 2022 | 35401678 | PubTator, text mining | PubMed |
| The Molecular Basis of Spinocerebellar Ataxia Type 7. | Front Neurosci | 2022 | 35401096 | PubTator, text mining | PubMed |
| Potential of nuclear magnetic resonance metabolomics in the study of prostate cancer. | Indian J Urol | 2022 | 35400867 | PubTator, text mining | PubMed |
| STRipy: A graphical application for enhanced genotyping of pathogenic short tandem repeats in sequencing data. | Hum Mutat | 2022 | 35395114 | PubTator, text mining | PubMed |
| Plasma PolyQ-ATXN3 Levels Associate With Cerebellar Degeneration and Behavioral Abnormalities in a New AAV-Based SCA3 Mouse Model. | Front Cell Dev Biol | 2022 | 35386195 | PubTator, text mining | PubMed |
| Mechanisms of Action of a Herbal Formula Huangqi Guizhi Wuwu Tang for the Management of Post-Stroke Related Numbness and Weakness: A Computational Molecular Docking Study. | J Evid Based Integr Med | 2022 | 35369720 | PubTator, text mining | PubMed |
| The CCAS-scale in hereditary ataxias: helpful on the group level, particularly in SCA3, but limited in individual patients. | J Neurol | 2022 | 35364683 | PubTator, text mining | PubMed |
| Contribution of CACNA1H Variants in Autism Spectrum Disorder Susceptibility. | Front Psychiatry | 2022 | 35350424 | PubTator, text mining | PubMed |
| The Clinical, Myopathological, and Genetic Analysis of 20 Patients With Non-dystrophic Myotonia. | Front Neurol | 2022 | 35350395 | PubTator, text mining | PubMed |
| RNA Sequencing of Lens Capsular Epithelium Implicates Novel Pathways in Pseudoexfoliation Syndrome. | Invest Ophthalmol Vis Sci | 2022 | 35348588 | PubTator, text mining | PubMed |
| Etiologic Classification of 541 Infantile Spasms Cases: A Cohort Study. | Front Pediatr | 2022 | 35330882 | PubTator, text mining | PubMed |
| In silico Analysis of Publicly Available Transcriptomics Data Identifies Putative Prognostic and Therapeutic Molecular Targets for Papillary Thyroid Carcinoma. | Int J Gen Med | 2022 | 35330879 | PubTator, text mining | PubMed |
| Sera Protein Signatures of Endometrial Cancer Lymph Node Metastases. | Int J Mol Sci | 2022 | 35328698 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/773/papers?page=46